创伤性脑损伤中调节性细胞死亡的研究进展
Research Progress on Regulated Cell Death in Traumatic Brain Injury
DOI: 10.12677/jcpm.2026.51038, PDF,   
作者: 沈嵩民, 孔繁栋:济宁医学院临床医学院(附属医院),山东 济宁;崔昌萌*:济宁医学院附属医院神经外科,山东 济宁
关键词: 创伤性脑损伤调节性细胞死亡凋亡自噬焦亡Traumatic Brain Injury Regulated Cell Death Apoptosis Autophagy Pyroptosis
摘要: 创伤性脑损伤(TBI)是全球范围内导致死亡与致残的主要原因之一,其发病机制复杂,涉及神经细胞死亡、炎症反应、氧化应激及线粒体功能障碍等多种病理过程。近年来,随着细胞死亡研究的深入,人们逐渐认识到调节性细胞死亡(RCD)在TBI中的关键作用。RCD是一类由特定信号通路和基因调控的主动细胞死亡方式,包括凋亡、自噬、焦亡、坏死性凋亡、铁死亡和铜死亡等。这些过程既参与神经元损伤后的细胞清除,在过度激活时同时也加剧了组织炎症和神经功能障碍。本文综述了不同类型RCD在TBI发生与发展的分子机制、相互作用及其潜在治疗策略的最新研究进展,为TBI的干预和神经保护提供新的理论依据。
Abstract: Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. Its pathogenesis is highly complex, involving multiple pathological processes such as neuronal cell death, inflammatory responses, oxidative stress, and mitochondrial dysfunction. In recent years, with advances in the study of cell death, increasing attention has been given to the critical role of regulated cell death (RCD) in TBI. RCD refers to a group of programmed cell death modalities controlled by specific signaling pathways and genetic regulation, including apoptosis, autophagy, pyroptosis, necroptosis, ferroptosis, and cuproptosis. These processes contribute to the clearance of damaged neural cells but, when excessively activated, can also exacerbate tissue inflammation and neurological dysfunction. This review summarizes the latest research progress on the molecular mechanisms, interactions, and potential therapeutic strategies of various RCD types in the occurrence and development of TBI, providing new theoretical insights for intervention and neuroprotection in TBI.
文章引用:沈嵩民, 孔繁栋, 崔昌萌. 创伤性脑损伤中调节性细胞死亡的研究进展[J]. 临床个性化医学, 2026, 5(1): 258-265. https://doi.org/10.12677/jcpm.2026.51038

参考文献

[1] Ye, Z., Li, Z., Zhong, S., Xing, Q., Li, K., Sheng, W., et al. (2024) The Recent Two Decades of Traumatic Brain Injury: A Bibliometric Analysis and Systematic Review. International Journal of Surgery, 110, 3745-3759. [Google Scholar] [CrossRef] [PubMed]
[2] Maas, A.I.R., Menon, D.K., Manley, G.T., Abrams, M., Åkerlund, C., Andelic, N., et al. (2022) Traumatic Brain Injury: Progress and Challenges in Prevention, Clinical Care, and Research. The Lancet Neurology, 21, 1004-1060. [Google Scholar] [CrossRef] [PubMed]
[3] Maldonado, J., Huang, J.H., Childs, E.W. and Tharakan, B. (2023) Racial/Ethnic Differences in Traumatic Brain Injury: Pathophysiology, Outcomes, and Future Directions. Journal of Neurotrauma, 40, 502-513. [Google Scholar] [CrossRef] [PubMed]
[4] Hajivalili, M., Nikkhoo, N., Salahi, S. and Hosseini, M. (2025) Traumatic Brain Injury: Comprehensive Overview from Pathophysiology to Mesenchymal Stem Cell-Based Therapies. International Immunopharmacology, 146, Article ID: 113816. [Google Scholar] [CrossRef] [PubMed]
[5] Galluzzi, L., Vitale, I., Aaronson, S.A., Abrams, J.M., Adam, D., Agostinis, P., et al. (2018) Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death & Differentiation, 25, 486-541. [Google Scholar] [CrossRef] [PubMed]
[6] Tang, D., Kang, R., Berghe, T.V., Vandenabeele, P. and Kroemer, G. (2019) The Molecular Machinery of Regulated Cell Death. Cell Research, 29, 347-364. [Google Scholar] [CrossRef] [PubMed]
[7] Guo, Z., Liu, Y., Chen, D., Sun, Y., Li, D., Meng, Y., et al. (2025) Targeting Regulated Cell Death: Apoptosis, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis in Anticancer Immunity. Journal of Translational Internal Medicine, 13, 10-32. [Google Scholar] [CrossRef] [PubMed]
[8] Hadian, K. and Stockwell, B.R. (2023) The Therapeutic Potential of Targeting Regulated Non-Apoptotic Cell Death. Nature Reviews Drug Discovery, 22, 723-742. [Google Scholar] [CrossRef] [PubMed]
[9] Newton, K., Strasser, A., Kayagaki, N. and Dixit, V.M. (2024) Cell Death. Cell, 187, 235-256. [Google Scholar] [CrossRef] [PubMed]
[10] Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., et al. (2022) Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins. Science, 375, 1254-1261. [Google Scholar] [CrossRef] [PubMed]
[11] Moyer, A., Tanaka, K. and Cheng, E.H. (2025) Apoptosis in Cancer Biology and Therapy. Annual Review of Pathology: Mechanisms of Disease, 20, 303-328. [Google Scholar] [CrossRef] [PubMed]
[12] Thapa, K., Khan, H., Singh, T.G. and Kaur, A. (2021) Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets. Journal of Molecular Neuroscience, 71, 1725-1742. [Google Scholar] [CrossRef] [PubMed]
[13] Unnisa, A., Greig, N.H. and Kamal, M.A. (2023) Inhibition of Caspase 3 and Caspase 9 Mediated Apoptosis: A Multimodal Therapeutic Target in Traumatic Brain Injury. Current Neuropharmacology, 21, 1001-1012. [Google Scholar] [CrossRef] [PubMed]
[14] Li, X., He, S. and Ma, B. (2020) Autophagy and Autophagy-Related Proteins in Cancer. Molecular Cancer, 19, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[15] Luo, C.L., Li, B.X., Li, Q.Q., Chen, X., Sun, Y., Bao, H., et al. (2011) Autophagy Is Involved in Traumatic Brain Injury-Induced Cell Death and Contributes to Functional Outcome Deficits in Mice. Neuroscience, 184, 54-63. [Google Scholar] [CrossRef] [PubMed]
[16] Pei, C., Li, B., Wen, S., Zhao, K., Yu, S., Li, T., et al. (2024) Neuron-Specific Deficiency of Autophagy Increases Neuronal Loss in Traumatic Brain Injury. PNAS Nexus, 3, pgae457. [Google Scholar] [CrossRef] [PubMed]
[17] Sarkar, C., Zhao, Z., Aungst, S., Sabirzhanov, B., Faden, A.I. and Lipinski, M.M. (2014) Impaired Autophagy Flux Is Associated with Neuronal Cell Death after Traumatic Brain Injury. Autophagy, 10, 2208-2222. [Google Scholar] [CrossRef] [PubMed]
[18] Tian, J., Mao, Y., Liu, D., Li, T., Wang, Y. and Zhu, C. (2025) Mitophagy in Brain Injuries: Mechanisms, Roles, and Therapeutic Potential. Molecular Neurobiology, 62, 10856-10868. [Google Scholar] [CrossRef] [PubMed]
[19] Liu, J., Zhu, Z., Wang, L., Du, J., Zhang, B., Feng, X., et al. (2020) Functional Suppression of Ripk1 Blocks the NF-κB Signaling Pathway and Induces Neuron Autophagy after Traumatic Brain Injury. Molecular and Cellular Biochemistry, 472, 105-114. [Google Scholar] [CrossRef] [PubMed]
[20] Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. (2015) Cleavage of GSDMD by Inflammatory Caspases Determines Pyroptotic Cell Death. Nature, 526, 660-665. [Google Scholar] [CrossRef] [PubMed]
[21] Huang, Y., Xu, W. and Zhou, R. (2021) NLRP3 Inflammasome Activation and Cell Death. Cellular & Molecular Immunology, 18, 2114-2127. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, H., Li, W., Chen, Z., Hu, Y., Zhang, D., Shen, W., et al. (2013) Expression of the NLRP3 Inflammasome in Cerebral Cortex after Traumatic Brain Injury in a Rat Model. Neurochemical Research, 38, 2072-2083. [Google Scholar] [CrossRef] [PubMed]
[23] Kuwar, R., Rolfe, A., Di, L., Xu, H., He, L., Jiang, Y., et al. (2019) A Novel Small Molecular NLRP3 Inflammasome Inhibitor Alleviates Neuroinflammatory Response Following Traumatic Brain Injury. Journal of Neuroinflammation, 16, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
[24] Yan, J., Wan, P., Choksi, S. and Liu, Z. (2022) Necroptosis and Tumor Progression. Trends in Cancer, 8, 21-27. [Google Scholar] [CrossRef] [PubMed]
[25] Wu, Y., Xu, Y., Sun, J., Dai, K., Wang, Z. and Zhang, J. (2024) Inhibiting RIPK1-Driven Neuroinflammation and Neuronal Apoptosis Mitigates Brain Injury Following Experimental Subarachnoid Hemorrhage. Experimental Neurology, 374, Article ID: 114705. [Google Scholar] [CrossRef] [PubMed]
[26] Hu, X., Xu, Y., Zhang, H., Li, Y., Wang, X., Xu, C., et al. (2022) Role of Necroptosis in Traumatic Brain and Spinal Cord Injuries. Journal of Advanced Research, 40, 125-134. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, Z., Chen, Q., Chen, Z., Tian, D., Li, M., Wang, J., et al. (2018) RIP3 Deficiency Protects against Traumatic Brain Injury (TBI) through Suppressing Oxidative Stress, Inflammation and Apoptosis: Dependent on AMPK Pathway. Biochemical and Biophysical Research Communications, 499, 112-119. [Google Scholar] [CrossRef] [PubMed]
[28] Dixon, S.J. and Olzmann, J.A. (2024) The Cell Biology of Ferroptosis. Nature Reviews Molecular Cell Biology, 25, 424-442. [Google Scholar] [CrossRef] [PubMed]
[29] Geng, Z., Guo, Z., Guo, R., Ye, R., Zhu, W. and Yan, B. (2021) Ferroptosis and Traumatic Brain Injury. Brain Research Bulletin, 172, 212-219. [Google Scholar] [CrossRef] [PubMed]
[30] Isaev, N.K., Stelmashook, E.V. and Genrikhs, E.E. (2019) Role of Zinc and Copper Ions in the Pathogenetic Mechanisms of Traumatic Brain Injury and Alzheimer’s Disease. Reviews in the Neurosciences, 31, 233-243. [Google Scholar] [CrossRef] [PubMed]
[31] Scheiber, I.F., Mercer, J.F.B. and Dringen, R. (2014) Metabolism and Functions of Copper in Brain. Progress in Neurobiology, 116, 33-57. [Google Scholar] [CrossRef] [PubMed]
[32] Li, P., Gao, Y., Tao, Z., Mu, Z., Du, S. and Zhao, X. (2025) PANoptosis: Cross-Talk among Apoptosis, Necroptosis, and Pyroptosis in Neurological Disorders. Journal of Inflammation Research, 18, 8131-8140. [Google Scholar] [CrossRef] [PubMed]
[33] Zhang, L., Hu, Z., Li, Z. and Lin, Y. (2023) Crosstalk among Mitophagy, Pyroptosis, Ferroptosis, and Necroptosis in Central Nervous System Injuries. Neural Regeneration Research, 19, 1660-1670. [Google Scholar] [CrossRef] [PubMed]
[34] Wei, Z., Yu, H., Zhao, H., Wei, M., Xing, H., Pei, J., et al. (2024) Broadening Horizons: Ferroptosis as a New Target for Traumatic Brain Injury. Burns & Trauma, 12, tkad051. [Google Scholar] [CrossRef] [PubMed]
[35] Hu, X., Chen, H., Xu, H., Wu, Y., Wu, C., Jia, C., et al. (2020) Role of Pyroptosis in Traumatic Brain and Spinal Cord Injuries. International Journal of Biological Sciences, 16, 2042-2050. [Google Scholar] [CrossRef] [PubMed]
[36] Li, S., Sun, Y., Song, M., Song, Y., Fang, Y., Zhang, Q., et al. (2021) NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis Exerts a Crucial Role in Astrocyte Pathological Injury in Mouse Model of Depression. JCI Insight, 6, e146852. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, A., Zhang, Z., Liu, Y., Lenahan, C., Xu, H., Jiang, J., et al. (2022) The Role of Caspase Family in Acute Brain Injury: The Potential Therapeutic Targets in the Future. Current Neuropharmacology, 20, 1194-1211. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, L. and Wang, H. (2018) Autophagy in Traumatic Brain Injury: A New Target for Therapeutic Intervention. Frontiers in Molecular Neuroscience, 11, Article 190. [Google Scholar] [CrossRef] [PubMed]
[39] Coll, R.C., Schroder, K. and Pelegrín, P. (2022) NLRP3 and Pyroptosis Blockers for Treating Inflammatory Diseases. Trends in Pharmacological Sciences, 43, 653-668. [Google Scholar] [CrossRef] [PubMed]
[40] Jantas, D. and Lasoń, W. (2021) Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications. Antioxidants, 10, Article 1518. [Google Scholar] [CrossRef] [PubMed]
[41] Shen, L., Lin, D., Li, X., Wu, H., Lenahan, C., Pan, Y., et al. (2020) Ferroptosis in Acute Central Nervous System Injuries: The Future Direction? Frontiers in Cell and Developmental Biology, 8, Article 594. [Google Scholar] [CrossRef] [PubMed]
[42] Li, L., Lv, L., Wang, Z., Liu, X., Wang, Q., Zhu, H., et al. (2025) From Copper Homeostasis to Cuproptosis: A New Perspective on CNS Immune Regulation and Neurodegenerative Diseases. Frontiers in Neurology, 16, Article 1581045. [Google Scholar] [CrossRef] [PubMed]